CHI3L2 and in situ carcinoma: –CHI3L1 correlates with disease progression–High CHI3L1 in CIS: rapidly converted to RRMS–Lower CHI3L2 in PMS than RRMS–CSF CHI3L1/CHI3L2 ratio discriminated PMS from RRMS